APO Research
Talk to an analyst

APO RESEARCH · REPORT

Single-Cell Multi-Omics Analysis Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Single-Cell Multi-Omics Analysis Platform Market Outlook and Growth Opportunities 2026

12 August 2026200 pages

Choose your research edition.

Industry ResearchSingle-Cell Multi-Omics Analysis Platform Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Single-Cell Multi-Omics Analysis Platform Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Single-Cell Multi-Omics Analysis Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Single-Cell Multi-Omics Analysis Platform Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Single-Cell Multi-Omics Analysis Platform Market Analysis and Forecast 2026-2032186 pages · $4,950 USD

Market perspective

The global Single-Cell Multi-Omics Analysis Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Single-Cell Multi-Omics Analysis Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Single-Cell Multi-Omics Analysis Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Single-Cell Multi-Omics Analysis Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Single-Cell Multi-Omics Analysis Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Single-Cell Multi-Omics Analysis Platform market include Parse Biosciences, Mission Bio, BioLegend, Singleron Biotechnologies, MGI Tech, BioSkryb Genomics, Scale Biosciences, Takara Bio and Cellenion, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Single-Cell Multi-Omics Analysis Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Single-Cell Multi-Omics Analysis Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Single-Cell Multi-Omics Analysis Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Single-Cell Multi-Omics Analysis Platform market.

Single-Cell Multi-Omics Analysis Platform Segment by Company

Parse Biosciences

Mission Bio

BioLegend

Singleron Biotechnologies

MGI Tech

BioSkryb Genomics

Scale Biosciences

Takara Bio

Cellenion

Dolomite Bio

Partek

BioTuring

QIAGEN

ROSALIND

CS Genetics

10x Genomics

BD

Illumina

Single-Cell Multi-Omics Analysis Platform Segment by Type

Transcriptome and Epigenome Platforms

Transcriptome and Proteome Platforms

Genome and Transcriptome Platforms

Genome and Proteome Platforms

Three-or-More-Omics Platforms

Other Multi-Omics Platforms

Single-Cell Multi-Omics Analysis Platform Segment by Application

Disease Mechanism Research

Drug Target and Biomarker Discovery

Cell and Gene Therapy Characterization

Clinical and Translational Research

Cell Atlas and Developmental Biology

Other Life Science Research

Single-Cell Multi-Omics Analysis Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Single-Cell Multi-Omics Analysis Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Single-Cell Multi-Omics Analysis Platform key companies, revenue, market share, and recent developments.

3. To split the Single-Cell Multi-Omics Analysis Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Single-Cell Multi-Omics Analysis Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Single-Cell Multi-Omics Analysis Platform significant trends, drivers, influence factors in global and regions.

6. To analyze Single-Cell Multi-Omics Analysis Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Single-Cell Multi-Omics Analysis Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Single-Cell Multi-Omics Analysis Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Single-Cell Multi-Omics Analysis Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Single-Cell Multi-Omics Analysis Platform industry.

Chapter 3: Detailed analysis of Single-Cell Multi-Omics Analysis Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Single-Cell Multi-Omics Analysis Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Single-Cell Multi-Omics Analysis Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Single-Cell Multi-Omics Analysis Platform Industry Trends Table 2. Single-Cell Multi-Omics Analysis Platform Industry Drivers Table 3. Single-Cell Multi-Omics Analysis Platform Industry Opportunities and Challenges Table 4. Single-Cell Multi-Omics Analysis Platform Industry Restraints Table 5. Global Single-Cell Multi-Omics Analysis Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Single-Cell Multi-Omics Analysis Platform Revenue Share by Company (2021-2026) Table 7. Global Single-Cell Multi-Omics Analysis Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Single-Cell Multi-Omics Analysis Platform Key Company Manufacturing Base & Headquarters Table 9. Global Single-Cell Multi-Omics Analysis Platform Company, Product Type & Application Table 10. Global Single-Cell Multi-Omics Analysis Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Single-Cell Multi-Omics Analysis Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Transcriptome and Epigenome Platforms Table 15. Significant Companies of Transcriptome and Proteome Platforms Table 16. Significant Companies of Genome and Transcriptome Platforms Table 17. Significant Companies of Genome and Proteome Platforms Table 18. Significant Companies of Three-or-More-Omics Platforms Table 19. Significant Companies of Other Multi-Omics Platforms Table 20. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type (2021-2026) Table 24. Global Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Disease Mechanism Research Table 26. Significant Companies of Drug Target and Biomarker Discovery Table 27. Significant Companies of Cell and Gene Therapy Characterization Table 28. Significant Companies of Clinical and Translational Research Table 29. Significant Companies of Cell Atlas and Developmental Biology Table 30. Significant Companies of Other Life Science Research Table 31. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Application (2021-2026) & (US$ Million) Table 33. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Application (2027-2032) & (US$ Million) Table 34. Global Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application (2021-2026) Table 35. Global Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application (2027-2032) Table 36. Global Single-Cell Multi-Omics Analysis Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Region (2021-2026) & (US$ Million) Table 38. Global Single-Cell Multi-Omics Analysis Platform Sales Value Share by Region (2021-2026) Table 39. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Region (2027-2032) & (US$ Million) Table 40. Global Single-Cell Multi-Omics Analysis Platform Sales Value Share by Region (2027-2032) Table 41. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Country (2021-2026) & (US$ Million) Table 43. Global Single-Cell Multi-Omics Analysis Platform Sales Value Market Share by Country (2021-2026) Table 44. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Country (2027-2032) & (US$ Million) Table 45. Global Single-Cell Multi-Omics Analysis Platform Sales Value Market Share by Country (2027-2032) Table 46. Parse Biosciences Company Information Table 47. Parse Biosciences Business Overview Table 48. Parse Biosciences Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Parse Biosciences Single-Cell Multi-Omics Analysis Platform Product Portfolio Table 50. Parse Biosciences Recent Development Table 51. Mission Bio Company Information Table 52. Mission Bio Business Overview Table 53. Mission Bio Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Mission Bio Single-Cell Multi-Omics Analysis Platform Product Portfolio Table 55. Mission Bio Recent Development Table 56. BioLegend Company Information Table 57. BioLegend Business Overview Table 58. BioLegend Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. BioLegend Single-Cell Multi-Omics Analysis Platform Product Portfolio Table 60. BioLegend Recent Development Table 61. Singleron Biotechnologies Company Information Table 62. Singleron Biotechnologies Business Overview Table 63. Singleron Biotechnologies Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Singleron Biotechnologies Single-Cell Multi-Omics Analysis Platform Product Portfolio Table 65. Singleron Biotechnologies Recent Development Table 66. MGI Tech Company Information Table 67. MGI Tech Business Overview Table 68. MGI Tech Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. MGI Tech Single-Cell Multi-Omics Analysis Platform Product Portfolio Table 70. MGI Tech Recent Development Table 71. BioSkryb Genomics Company Information Table 72. BioSkryb Genomics Business Overview Table 73. BioSkryb Genomics Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. BioSkryb Genomics Single-Cell Multi-Omics Analysis Platform Product Portfolio Table 75. BioSkryb Genomics Recent Development Table 76. Scale Biosciences Company Information Table 77. Scale Biosciences Business Overview Table 78. Scale Biosciences Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Scale Biosciences Single-Cell Multi-Omics Analysis Platform Product Portfolio Table 80. Scale Biosciences Recent Development Table 81. Takara Bio Company Information Table 82. Takara Bio Business Overview Table 83. Takara Bio Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Takara Bio Single-Cell Multi-Omics Analysis Platform Product Portfolio Table 85. Takara Bio Recent Development Table 86. Cellenion Company Information Table 87. Cellenion Business Overview Table 88. Cellenion Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Cellenion Single-Cell Multi-Omics Analysis Platform Product Portfolio Table 90. Cellenion Recent Development Table 91. Dolomite Bio Company Information Table 92. Dolomite Bio Business Overview Table 93. Dolomite Bio Single-Cell Multi-Omics Analysis Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Dolomite Bio Single-Cell Multi-Omics Analysis Platform Product Portfolio Table 95. Dolomite Bio Recent Development Table 96. Partek Company Information Table 97. Partek Business Overview Table 98. Partek Single-Cell Multi-Omics Analysis Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Partek Single-Cell Multi-Omics Analysis Platform Product Portfolio Table 100. Partek Recent Development Table 101. BioTuring Company Information Table 102. BioTuring Business Overview Table 103. BioTuring Single-Cell Multi-Omics Analysis Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. BioTuring Single-Cell Multi-Omics Analysis Platform Product Portfolio Table 105. BioTuring Recent Development Table 106. QIAGEN Company Information Table 107. QIAGEN Business Overview Table 108. QIAGEN Single-Cell Multi-Omics Analysis Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. QIAGEN Single-Cell Multi-Omics Analysis Platform Product Portfolio Table 110. QIAGEN Recent Development Table 111. ROSALIND Company Information Table 112. ROSALIND Business Overview Table 113. ROSALIND Single-Cell Multi-Omics Analysis Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. ROSALIND Single-Cell Multi-Omics Analysis Platform Product Portfolio Table 115. ROSALIND Recent Development Table 116. CS Genetics Company Information Table 117. CS Genetics Business Overview Table 118. CS Genetics Single-Cell Multi-Omics Analysis Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. CS Genetics Single-Cell Multi-Omics Analysis Platform Product Portfolio Table 120. CS Genetics Recent Development Table 121. 10x Genomics Company Information Table 122. 10x Genomics Business Overview Table 123. 10x Genomics Single-Cell Multi-Omics Analysis Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. 10x Genomics Single-Cell Multi-Omics Analysis Platform Product Portfolio Table 125. 10x Genomics Recent Development Table 126. BD Company Information Table 127. BD Business Overview Table 128. BD Single-Cell Multi-Omics Analysis Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. BD Single-Cell Multi-Omics Analysis Platform Product Portfolio Table 130. BD Recent Development Table 131. Illumina Company Information Table 132. Illumina Business Overview Table 133. Illumina Single-Cell Multi-Omics Analysis Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Illumina Single-Cell Multi-Omics Analysis Platform Product Portfolio Table 135. Illumina Recent Development Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Single-Cell Multi-Omics Analysis Platform Product Image Figure 2. Global Single-Cell Multi-Omics Analysis Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Single-Cell Multi-Omics Analysis Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global Single-Cell Multi-Omics Analysis Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Transcriptome and Epigenome Platforms Image Figure 8. Transcriptome and Proteome Platforms Image Figure 9. Genome and Transcriptome Platforms Image Figure 10. Genome and Proteome Platforms Image Figure 11. Three-or-More-Omics Platforms Image Figure 12. Other Multi-Omics Platforms Image Figure 13. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Single-Cell Multi-Omics Analysis Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type (2021-2032) Figure 16. Disease Mechanism Research Image Figure 17. Drug Target and Biomarker Discovery Image Figure 18. Cell and Gene Therapy Characterization Image Figure 19. Clinical and Translational Research Image Figure 20. Cell Atlas and Developmental Biology Image Figure 21. Other Life Science Research Image Figure 22. Global Single-Cell Multi-Omics Analysis Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Single-Cell Multi-Omics Analysis Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application (2021-2032) Figure 25. Global Single-Cell Multi-Omics Analysis Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 26. Global Single-Cell Multi-Omics Analysis Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 27. North America Single-Cell Multi-Omics Analysis Platform Sales Value (2021-2032) & (US$ Million) Figure 28. North America Single-Cell Multi-Omics Analysis Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Europe Single-Cell Multi-Omics Analysis Platform Sales Value (2021-2032) & (US$ Million) Figure 30. Europe Single-Cell Multi-Omics Analysis Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Asia-Pacific Single-Cell Multi-Omics Analysis Platform Sales Value (2021-2032) & (US$ Million) Figure 32. Asia-Pacific Single-Cell Multi-Omics Analysis Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 33. South America Single-Cell Multi-Omics Analysis Platform Sales Value (2021-2032) & (US$ Million) Figure 34. South America Single-Cell Multi-Omics Analysis Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Middle East & Africa Single-Cell Multi-Omics Analysis Platform Sales Value (2021-2032) & (US$ Million) Figure 36. Middle East & Africa Single-Cell Multi-Omics Analysis Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 37. USA Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. USA Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. USA Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Canada Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Canada Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Canada Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Mexico Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Mexico Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Mexico Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Germany Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Germany Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Germany Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. France Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. France Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. France Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. U.K. Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. U.K. Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. U.K. Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Italy Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Italy Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Italy Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Spain Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Spain Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Spain Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Russia Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Russia Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Russia Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Netherlands Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Netherlands Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Netherlands Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Nordic Countries Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Nordic Countries Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Nordic Countries Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. China Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. China Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. China Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Japan Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Japan Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Japan Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. South Korea Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. South Korea Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. South Korea Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. India Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. India Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. India Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Australia Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Australia Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Australia Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Southeast Asia Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Southeast Asia Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Southeast Asia Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Brazil Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Brazil Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Brazil Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Argentina Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Argentina Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Argentina Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Chile Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Chile Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Chile Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Colombia Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Colombia Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Colombia Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Peru Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Peru Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Peru Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Saudi Arabia Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Israel Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Israel Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Israel Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. UAE Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. UAE Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. UAE Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Turkey Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Turkey Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Turkey Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Iran Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Iran Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Iran Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Egypt Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Egypt Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Egypt Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Years Considered Figure 122. Research Process Figure 123. Key Executives Interviewed

Scope & coverage.

Types
  • Transcriptome and Epigenome Platforms
  • Transcriptome and Proteome Platforms
  • Genome and Transcriptome Platforms
  • Genome and Proteome Platforms
  • Three-or-More-Omics Platforms
  • Other Multi-Omics Platforms
Applications
  • Disease Mechanism Research
  • Drug Target and Biomarker Discovery
  • Cell and Gene Therapy Characterization
  • Clinical and Translational Research
  • Cell Atlas and Developmental Biology
  • Other Life Science Research
Companies covered
  • Parse Biosciences
  • Mission Bio
  • BioLegend
  • Singleron Biotechnologies
  • MGI Tech
  • BioSkryb Genomics
  • Scale Biosciences
  • Takara Bio
  • Cellenion
  • Dolomite Bio
  • Partek
  • BioTuring
  • QIAGEN
  • ROSALIND
  • CS Genetics
  • 10x Genomics
  • BD
  • Illumina

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Single-Cell Multi-Omics Analysis Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Single-Cell Multi-Omics Analysis Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Single-Cell Multi-Omics Analysis Platform Market Dynamics
  1. 2.1 Single-Cell Multi-Omics Analysis Platform Industry Trends
  2. 2.2 Single-Cell Multi-Omics Analysis Platform Industry Drivers
  3. 2.3 Single-Cell Multi-Omics Analysis Platform Industry Opportunities and Challenges
  4. 2.4 Single-Cell Multi-Omics Analysis Platform Industry Restraints
3 Single-Cell Multi-Omics Analysis Platform Market by Company
  1. 3.1 Global Single-Cell Multi-Omics Analysis Platform Company Revenue Ranking in 2025
  2. 3.2 Global Single-Cell Multi-Omics Analysis Platform Revenue by Company (2021-2026)
  3. 3.3 Global Single-Cell Multi-Omics Analysis Platform Company Ranking (2024-2026)
  4. 3.4 Global Single-Cell Multi-Omics Analysis Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global Single-Cell Multi-Omics Analysis Platform Company Product Type and Application
  6. 3.6 Global Single-Cell Multi-Omics Analysis Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Single-Cell Multi-Omics Analysis Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Single-Cell Multi-Omics Analysis Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Single-Cell Multi-Omics Analysis Platform Market by Type
  1. 4.1 Single-Cell Multi-Omics Analysis Platform Type Introduction
  2. 4.1.1 Transcriptome and Epigenome Platforms
  3. 4.1.2 Transcriptome and Proteome Platforms
  4. 4.1.3 Genome and Transcriptome Platforms
  5. 4.1.4 Genome and Proteome Platforms
  6. 4.1.5 Three-or-More-Omics Platforms
  7. 4.1.6 Other Multi-Omics Platforms
  8. 4.2 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Type
  9. 4.2.1 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Type (2021-2032)
  11. 4.2.3 Global Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type (2021-2032)
5 Single-Cell Multi-Omics Analysis Platform Market by Application
  1. 5.1 Single-Cell Multi-Omics Analysis Platform Application Introduction
  2. 5.1.1 Disease Mechanism Research
  3. 5.1.2 Drug Target and Biomarker Discovery
  4. 5.1.3 Cell and Gene Therapy Characterization
  5. 5.1.4 Clinical and Translational Research
  6. 5.1.5 Cell Atlas and Developmental Biology
  7. 5.1.6 Other Life Science Research
  8. 5.2 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Application
  9. 5.2.1 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Application (2021-2032)
  11. 5.2.3 Global Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application (2021-2032)
6 Single-Cell Multi-Omics Analysis Platform Regional Value Analysis
  1. 6.1 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Single-Cell Multi-Omics Analysis Platform Sales Value (2021-2032)
  7. 6.3.2 North America Single-Cell Multi-Omics Analysis Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Single-Cell Multi-Omics Analysis Platform Sales Value (2021-2032)
  10. 6.4.2 Europe Single-Cell Multi-Omics Analysis Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Single-Cell Multi-Omics Analysis Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Single-Cell Multi-Omics Analysis Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Single-Cell Multi-Omics Analysis Platform Sales Value (2021-2032)
  16. 6.6.2 South America Single-Cell Multi-Omics Analysis Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Single-Cell Multi-Omics Analysis Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Single-Cell Multi-Omics Analysis Platform Sales Value Share by Country, 2025 VS 2032
7 Single-Cell Multi-Omics Analysis Platform Country-level Value Analysis
  1. 7.1 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global Single-Cell Multi-Omics Analysis Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Single-Cell Multi-Omics Analysis Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Single-Cell Multi-Omics Analysis Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Single-Cell Multi-Omics Analysis Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Parse Biosciences
  2. 8.1.1 Parse Biosciences Company Information
  3. 8.1.2 Parse Biosciences Business Overview
  4. 8.1.3 Parse Biosciences Single-Cell Multi-Omics Analysis Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Parse Biosciences Single-Cell Multi-Omics Analysis Platform Product Portfolio
  6. 8.1.5 Parse Biosciences Recent Developments
  7. 8.2 Mission Bio
  8. 8.2.1 Mission Bio Company Information
  9. 8.2.2 Mission Bio Business Overview
  10. 8.2.3 Mission Bio Single-Cell Multi-Omics Analysis Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mission Bio Single-Cell Multi-Omics Analysis Platform Product Portfolio
  12. 8.2.5 Mission Bio Recent Developments
  13. 8.3 BioLegend
  14. 8.3.1 BioLegend Company Information
  15. 8.3.2 BioLegend Business Overview
  16. 8.3.3 BioLegend Single-Cell Multi-Omics Analysis Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BioLegend Single-Cell Multi-Omics Analysis Platform Product Portfolio
  18. 8.3.5 BioLegend Recent Developments
  19. 8.4 Singleron Biotechnologies
  20. 8.4.1 Singleron Biotechnologies Company Information
  21. 8.4.2 Singleron Biotechnologies Business Overview
  22. 8.4.3 Singleron Biotechnologies Single-Cell Multi-Omics Analysis Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Singleron Biotechnologies Single-Cell Multi-Omics Analysis Platform Product Portfolio
  24. 8.4.5 Singleron Biotechnologies Recent Developments
  25. 8.5 MGI Tech
  26. 8.5.1 MGI Tech Company Information
  27. 8.5.2 MGI Tech Business Overview
  28. 8.5.3 MGI Tech Single-Cell Multi-Omics Analysis Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MGI Tech Single-Cell Multi-Omics Analysis Platform Product Portfolio
  30. 8.5.5 MGI Tech Recent Developments
  31. 8.6 BioSkryb Genomics
  32. 8.6.1 BioSkryb Genomics Company Information
  33. 8.6.2 BioSkryb Genomics Business Overview
  34. 8.6.3 BioSkryb Genomics Single-Cell Multi-Omics Analysis Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BioSkryb Genomics Single-Cell Multi-Omics Analysis Platform Product Portfolio
  36. 8.6.5 BioSkryb Genomics Recent Developments
  37. 8.7 Scale Biosciences
  38. 8.7.1 Scale Biosciences Company Information
  39. 8.7.2 Scale Biosciences Business Overview
  40. 8.7.3 Scale Biosciences Single-Cell Multi-Omics Analysis Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Scale Biosciences Single-Cell Multi-Omics Analysis Platform Product Portfolio
  42. 8.7.5 Scale Biosciences Recent Developments
  43. 8.8 Takara Bio
  44. 8.8.1 Takara Bio Company Information
  45. 8.8.2 Takara Bio Business Overview
  46. 8.8.3 Takara Bio Single-Cell Multi-Omics Analysis Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Takara Bio Single-Cell Multi-Omics Analysis Platform Product Portfolio
  48. 8.8.5 Takara Bio Recent Developments
  49. 8.9 Cellenion
  50. 8.9.1 Cellenion Company Information
  51. 8.9.2 Cellenion Business Overview
  52. 8.9.3 Cellenion Single-Cell Multi-Omics Analysis Platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cellenion Single-Cell Multi-Omics Analysis Platform Product Portfolio
  54. 8.9.5 Cellenion Recent Developments
  55. 8.10 Dolomite Bio
  56. 8.10.1 Dolomite Bio Company Information
  57. 8.10.2 Dolomite Bio Business Overview
  58. 8.10.3 Dolomite Bio Single-Cell Multi-Omics Analysis Platform Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Dolomite Bio Single-Cell Multi-Omics Analysis Platform Product Portfolio
  60. 8.10.5 Dolomite Bio Recent Developments
  61. 8.11 Partek
  62. 8.11.1 Partek Company Information
  63. 8.11.2 Partek Business Overview
  64. 8.11.3 Partek Single-Cell Multi-Omics Analysis Platform Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Partek Single-Cell Multi-Omics Analysis Platform Product Portfolio
  66. 8.11.5 Partek Recent Developments
  67. 8.12 BioTuring
  68. 8.12.1 BioTuring Company Information
  69. 8.12.2 BioTuring Business Overview
  70. 8.12.3 BioTuring Single-Cell Multi-Omics Analysis Platform Revenue and Gross Margin (2021-2026)
  71. 8.12.4 BioTuring Single-Cell Multi-Omics Analysis Platform Product Portfolio
  72. 8.12.5 BioTuring Recent Developments
  73. 8.13 QIAGEN
  74. 8.13.1 QIAGEN Company Information
  75. 8.13.2 QIAGEN Business Overview
  76. 8.13.3 QIAGEN Single-Cell Multi-Omics Analysis Platform Revenue and Gross Margin (2021-2026)
  77. 8.13.4 QIAGEN Single-Cell Multi-Omics Analysis Platform Product Portfolio
  78. 8.13.5 QIAGEN Recent Developments
  79. 8.14 ROSALIND
  80. 8.14.1 ROSALIND Company Information
  81. 8.14.2 ROSALIND Business Overview
  82. 8.14.3 ROSALIND Single-Cell Multi-Omics Analysis Platform Revenue and Gross Margin (2021-2026)
  83. 8.14.4 ROSALIND Single-Cell Multi-Omics Analysis Platform Product Portfolio
  84. 8.14.5 ROSALIND Recent Developments
  85. 8.15 CS Genetics
  86. 8.15.1 CS Genetics Company Information
  87. 8.15.2 CS Genetics Business Overview
  88. 8.15.3 CS Genetics Single-Cell Multi-Omics Analysis Platform Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CS Genetics Single-Cell Multi-Omics Analysis Platform Product Portfolio
  90. 8.15.5 CS Genetics Recent Developments
  91. 8.16 10x Genomics
  92. 8.16.1 10x Genomics Company Information
  93. 8.16.2 10x Genomics Business Overview
  94. 8.16.3 10x Genomics Single-Cell Multi-Omics Analysis Platform Revenue and Gross Margin (2021-2026)
  95. 8.16.4 10x Genomics Single-Cell Multi-Omics Analysis Platform Product Portfolio
  96. 8.16.5 10x Genomics Recent Developments
  97. 8.17 BD
  98. 8.17.1 BD Company Information
  99. 8.17.2 BD Business Overview
  100. 8.17.3 BD Single-Cell Multi-Omics Analysis Platform Revenue and Gross Margin (2021-2026)
  101. 8.17.4 BD Single-Cell Multi-Omics Analysis Platform Product Portfolio
  102. 8.17.5 BD Recent Developments
  103. 8.18 Illumina
  104. 8.18.1 Illumina Company Information
  105. 8.18.2 Illumina Business Overview
  106. 8.18.3 Illumina Single-Cell Multi-Omics Analysis Platform Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Illumina Single-Cell Multi-Omics Analysis Platform Product Portfolio
  108. 8.18.5 Illumina Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst